# Inhibikase Therapeutics, Inc.: Form 8-K, filed Nov 20, 2025

- Company: [Inhibikase Therapeutics, Inc.](/companies/ikt.md) (CIK 1750149)
- Form: 8-K
- Filed: 2025-11-20
- Accepted by EDGAR: Nov 20, 2025, 21:11 ET
- Period: 2025-11-20
- Accession: 0001193125-25-289768
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1750149/000119312525289768/d20255d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750149/000119312525289768/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750149/000119312525289768/d20255d8k.htm

Filed Nov 20, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-289768. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.